healthday on MSN1h
AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With Cardiovascular RiskMuvalaplin reduces lipoprotein(a) levels, according to a study published online Nov. 20 in the Journal of the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback